Association between the CTGF -945C/G polymorphism and systemic sclerosis: A meta-analysis

Gene

Volumn 509, Issue 1, 2012, Pages 1-6

  Zhang, Xiufeng ^a,b   Nie, Shengjie ^a   Si, Xiaoyu ^b   Luo, Ying ^b   Tang, Wenru ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CTGF 945C G; Meta analysis; SSc

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ASIAN; CAUCASIAN; CONNECTIVE TISSUE GROWTH FACTOR GENE; GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MEDLINE; PRIORITY JOURNAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CONNECTIVE TISSUE GROWTH FACTOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCLERODERMA, SYSTEMIC;

EID: 84866182297     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.061     Document Type: Review

References (35)

1. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 2002, 4:599-604.
2. Adiga S.K., Jayarawan V., Kalthur G., Upadhya D., Kumar P. Declining semen quality among south Indian infertile men: a retrospective study. J. Hum. Reprod. Sci. 2008, 1:15-18.
3. Agarwal S.K. The genetics of systemic sclerosis. Discov. Med. 2010, 10:134-143.
4. Agarwal S.K., Tan F.K., Arnett F.C. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum. Dis. Clin. North Am. 2008, 34:17-40. v.
5. Arnott J.A., et al. The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit. Rev. Eukaryot. Gene Expr. 2011, 21:43-69.
6. Broen J.C., Coenen M.J., Radstake T.R. Genetics of systemic sclerosis: an update. Curr. Rheumatol. Rep. 2012, 14:11-21.
7. Chen P.S., et al. CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. J. Cell Sci. 2007, 120:2053-2065.
8. Cozzolino M., et al. CCN2 (CTGF) gene polymorphism is a novel prognostic risk factor for cardiovascular outcomes in hemodialysis patients. Blood Purif. 2010, 30:272-276.
9. Dendooven A., Gerritsen K.G., Nguyen T.Q., Kok R.J., Goldschmeding R. Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis. Biomarkers 2011, 16:289-301.
10. Denton C.P., Black C.M., Abraham D.J. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat. Clin. Pract. Rheumatol. 2006, 2:134-144.
11. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
12. Dieude P., et al. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum. 2009, 60:2472-2479.
13. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
14. Fonseca C., et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N. Engl. J. Med. 2007, 357:1210-1220.
15. Fox R.I., Kang H.I. Genetic and environmental factors in systemic sclerosis. Curr. Opin. Rheumatol. 1992, 4:857-861.
16. Frazier K., Williams S., Kothapalli D., Klapper H., Grotendorst G.R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 1996, 107:404-411.
17. Gourh P., Mayes M.D., Arnett F.C. CTGF polymorphism associated with systemic sclerosis. N. Engl. J. Med. 2008, 358:308-309. (author reply 309).
18. Gourh P., et al. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. Arthritis Rheum. 2009, 60:3794-3806.
19. Granel B., et al. Association between a CTGF gene polymorphism and systemic sclerosis in a French population. J. Rheumatol. 2010, 37:351-358.
20. Igarashi A., et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol. 1995, 105:280-284.
21. Igarashi A., et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J. Invest. Dermatol. 1996, 106:729-733.
22. Kawaguchi Y., et al. Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann. Rheum. Dis. 2009, 68:1921-1924.
23. Lai K.B., Sanderson J.E., Yu C.M. The regulatory effect of norepinephrine on connective tissue growth factor (CTGF) and vascular endothelial growth factor (VEGF) expression in cultured cardiac fibroblasts. Int. J. Cardiol. 2011, (Electronic publication ahead of print).
24. Louthrenoo W., et al. Lack of CTGF*-945C/G dimorphism in Thai patients with systemic sclerosis. Open Rheumatol. J. 2011, 5:59-63.
25. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
26. Mayes M.D., Trojanowska M. Genetic factors in systemic sclerosis. Arthritis Res. Ther. 2007, 9(Suppl. 2):S5.
27. Morita H., Hayashi D., Nagai R. CTGF polymorphism associated with systemic sclerosis. N. Engl. J. Med. 2008, 358:308. (author reply 309).
28. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004, 363:62-64.
29. Pivovarova O., et al. A polymorphism within the connective tissue growth factor (CTGF) gene has no effect on non-invasive markers of beta-cell area and risk of type 2 diabetes. Dis. Markers 2011, 31:241-246.
30. Planque N., Perbal B. A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int. 2003, 3:15.
31. Ranque B., Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun. Rev. 2010, 9:A311-A318.
32. Reveille J.D. Genetic studies in the rheumatic diseases: present status and implications for the future. J. Rheumatol. Suppl. 2005, 72:10-13.
33. Rueda B., et al. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann. Rheum. Dis. 2009, 68:1618-1620.
34. Shi-Wen X., Leask A., Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008, 19:133-144.
35. Tall E.G., Bernstein A.M., Oliver N., Gray J.L., Masur S.K. TGF-beta-stimulated CTGF production enhanced by collagen and associated with biogenesis of a novel 31-kDa CTGF form in human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2010, 51:5002-5011.